Cargando…
Should patients on levothyroxine therapy be screened for pancreatic cancer?
BACKGROUND: Pancreatic ductal adenocarcinoma is an aggressive disease with increasing incidence. Thyroid hormones play different roles in development and physiological processes of the entire digestive system, including pancreas. Therefore, many have hypothesized that thyroid hormone supplementation...
Autores principales: | Garajová, Ingrid, Balsano, Rita, Coriano’, Matilde, Gelsomino, Fabio, Tovoli, Francesco, De Lorenzo, Stefania, Del Rio, Paolo, Dalla Valle, Raffaele, Ravaioli, Matteo, Leonardi, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828906/ https://www.ncbi.nlm.nih.gov/pubmed/36533763 http://dx.doi.org/10.23750/abm.v93i6.13366 |
Ejemplares similares
-
The implication of liquid biopsies to predict chemoresistance in pancreatic cancer
por: Pietri, Elisabetta, et al.
Publicado: (2021) -
Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection
por: Garajova, Ingrid, et al.
Publicado: (2021) -
It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer
por: Garajová, Ingrid, et al.
Publicado: (2022) -
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials
por: Tovoli, Francesco, et al.
Publicado: (2021) -
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
por: Garajová, Ingrid, et al.
Publicado: (2023)